SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status
-
* Corresponding author: Ayad M Al-Katib alkatib@med.wayne.edu
Journal of Hematology & Oncology 2009, 2:8 doi:10.1186/1756-8722-2-8
No comments have yet been made on this article.